Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant Topoisomerase II alpha anticorps (AA 1300-1500)

Cet anticorps anti-Topoisomerase II alpha Monoclonal Souris (Clone rTOP2A-8339) (ABIN7859104) détecte spécifiquement Topoisomerase II alpha dans WB et IHC. L’anticorps est réactif avec des échantillons de Humain.
N° du produit ABIN7859104
639,45 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Recombinant Topoisomerase II alpha anticorps (AA 1300-1500) (ABIN7859104)

Antigène

Voir toutes Topoisomerase II alpha (TOP2A) Anticorps
Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 191
  • 85
  • 46
  • 9
  • 6
  • 3
  • 3
  • 3
  • 1
Humain

Hôte

  • 141
  • 51
Souris

Clonalité

  • 99
  • 93
Monoclonal

Conjugué

  • 119
  • 10
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Topoisomerase II alpha est non-conjugé

Application

  • 132
  • 91
  • 52
  • 52
  • 40
  • 23
  • 18
  • 9
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)

Clone

RTOP2A-8339
  • Épitope

    • 30
    • 15
    • 14
    • 11
    • 10
    • 9
    • 8
    • 7
    • 6
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1300-1500

    Fonction

    Recombinant Topoisomerase II alpha (Proliferation & Drug-Resistance Marker) Antibody

    Specificité

    It recognizes a 170kDa protein, which is identified as topoisomerase II±. It shows no cross-reaction with Topoisomerase II ≤ or I. Topo II ± plays important roles in synthesis and transcription of DNA as well as chromosomal segregation during mitosis. It is reported to be a sensitive and specific marker of late S-, G2- & M-phases in transformed and developmentally regulated normal cells. Topo II ± is also implicated in drug resistance of tumor cells and has been shown to be over-expressed in many human cancers. Decreased expression of Topo IIa is the predominant mechanism of resistance to several chemotherapeutic agents.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant human Topoisomerase II alpha fragment (aa1300-1500) (exact sequence is proprietary)

    Isotype

    IgG1, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Antigène

    Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

    Autre désignation

    Topoisomerase II alpha

    Sujet

    ATP hydrolyzing DNA topoisomerase II alfa, DNA gyrase, DNA topoisomerase (ATP hydrolyzing), DNA topoisomerase 2 alpha, DNA topoisomerase II 170kD, DNA topoisomerase II alpha, DNA Topoisomerase2, TOP2A, Topoisomerase DNA II alpha 170 kDa, TP2A

    HeLa or Jurkat cells. Human lymph node or tonsil. A549.

    Poids moléculaire

    170kDa

    ID gène

    7153, 156346

    UniProt

    P11388

    Pathways

    Cycle Cellulaire, Mitotic G1-G1/S Phases
Vous êtes ici:
Chat with us!